Search research articles
Contact Us
Filters
Showing results (311-320 of 316) with videos related to
Page
of 32
Sort By:
You have reached the last page of results.
This site can display upto 316 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Blood Advances
|
August 2, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, et al.
Bone Marrow Transplantation
|
August 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
Timothy E O'Connor, Chenyu Lin, Gregory W Roloff, et al.
Blood
|
February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Cancer Cell
|
July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Daniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 23, 2022
Genome-wide analyses of individual differences in quantitatively assessed reading- and language-related skills in up to 34,000 people
Else Eising, Nazanin Mirza-Schreiber, Eveline L de Zeeuw, et al.
Page
of 32
Search research articles
Search
Showing results (311-320 of 316) with videos related to
Sort By:
Page
of 32
You have reached the last page of results.
This site can display upto 316 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Blood Advances
|
August 2, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, et al.
Bone Marrow Transplantation
|
August 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
Timothy E O'Connor, Chenyu Lin, Gregory W Roloff, et al.
Blood
|
February 5, 2026
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang, et al.
Cancer Cell
|
July 22, 2022
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Daniel Bottomly, Nicola Long, Anna Reister Schultz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 23, 2022
Genome-wide analyses of individual differences in quantitatively assessed reading- and language-related skills in up to 34,000 people
Else Eising, Nazanin Mirza-Schreiber, Eveline L de Zeeuw, et al.
Page
of 32